Chinese Firm Hit With Pandemic's First Remote-Records-Based FDA Drug GMP Warning Letter
Import alert and warning letter came after Ningbo, China, over-the-counter skin care products firm failed to share requested testing records.
Import alert and warning letter came after Ningbo, China, over-the-counter skin care products firm failed to share requested testing records.